ISIS 304801
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISIS 304801, covering 2020-10-20 to 2020-10-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension [Phase 2]